Repaglinide (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Repaglinide drug offered from Mylan Institutional Inc.. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | repaglinide |
| SUBSTANCE NAME: | REPAGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-11-21 |
| END MARKETING DATE: | 0000-00-00 |
Repaglinide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Repaglinide from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2013-11-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-062_5bed7cb1-1e65-202e-e053-2a91aa0a9886 |
| PRODUCT NDC: | 51079-062 |
| APPLICATION NUMBER: | ANDA090252 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers:
